(Q53122367)

English

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

ulcerative colitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

22

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Martti Färkkilä

23

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Javier P Gisbert

24

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

object named as

Maria Nachury

9

0 references

Gert Van Assche

21

object named as

Gert Van Assche

1 reference

Europe PubMed Central

11 May 2018

Jean-Frédéric Colombel

30

object named as

Jean-Frederic Colombel

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

author name string

David Laharie

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Arnaud Bourreille

2

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Julien Branche

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Matthieu Allez

4

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Yoram Bouhnik

5

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jerome Filippi

6

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Frank Zerbib

7

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Guillaume Savoye

8

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jacques Moreau

10

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jean-Charles Delchier

11

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jacques Cosnes

12

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Elena Ricart

13

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Olivier Dewit

14

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Antonio Lopez-Sanroman

15

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jean-Louis Dupas

16

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Franck Carbonnel

17

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Gilles Bommelaer

18

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Benoit Coffin

19

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Xavier Roblin

20

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Philippe Marteau

25

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Stephane Nahon

26

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Martine de Vos

27

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Denis Franchimont

28

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jean-Yves Mary

29

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Marc Lémann

31

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

32

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

language of work or name

0 references

publication date

10 October 2012

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

380

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

9857

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

1909-1915

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The pattern and outcome of acute severe colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

European evidence-based Consensus on the management of ulcerative colitis: Current management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Power and sample size calculations. A review and computer program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab efficacy in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61084-8

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23063316

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53122367&oldid=1578270122"